NOT-EB-22-016: Notice of Change in Application Due Date for RFA-EB-21-001

Notice of Change in Application Due Date for RFA-EB-21-001

Notice Number:

NOT-EB-22-016

Key Dates

Release Date:

January 11, 2023

Related Announcements

NOT-EB-24-002 - Notice of Changes to RFA-EB-21-001, "Technology Development to Reduce Health Disparities (R01 Clinical Trial Optional)"

RFA-EB-21-001 - Technology Development to Reduce Health Disparities (R01 Clinical Trial Optional)

Issued by

National Institute of Biomedical Imaging and Bioengineering (NIBIB)

National Institute on Minority Health and Health Disparities (NIMHD)

Purpose

The purpose of this notice is to inform potential applicants of changes to the Application Due Date for RFA-EB-21-001 "Technology Development to Reduce Health Disparities (R01 Clinical Trial Optional)". The following section has been modified to reflect changes to the due date for new applications:

Key Dates

Currently reads:

Application Due Date(s)

February 11, 2022, January 26, 2023, and January 26, 2024 by 5:00 PM local time of applicant organization.

AIDS Application Due Date(s)

May 02, 2022, May 03, 2023, and May 02, 2024 by 5:00 PM local time of applicant organization.

Modified to read (changes shown in bold italics):

Application Due Date(s)

February 11, 2022, January 26, 2023, May 31, 2023, and January 26, 2024 by 5:00 PM local time of applicant organization.

AIDS Application Due Date(s)

May 02, 2022, May 03, 2023, September 6, 2023, and May 02, 2024 by 5:00 PM local time of applicant organization.

All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Moria Bittmann, Ph.D.
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Telephone: 301-496-7699
Email: [email protected]

Deborah E. Linares, Ph.D., M.A.
National Institute on Minority Health and Health Disparities (NIMHD)
Phone: 301-402-2516
E-mail: [email protected]